Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme
- PMID: 17453007
- PMCID: PMC2359913
- DOI: 10.1038/sj.bjc.6603759
Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme
Abstract
We evaluated the sensitivity for colorectal cancer (CRC) of the latex agglutination test (LAT), an immunochemical test routinely used in the Florence District screening programme since 2000. Sensitivity was calculated by the proportional interval cancer incidence method in a population of 27,503 consecutive subjects screened in 2000-2002, interval cancers being identified by linkage to the Tuscany Cancer Registry files. Sensitivity was calculated overall and by gender, age, time since last negative LAT, CRC site, and rank of screening. Overall 1- and 2-year sensitivity estimates were 80.7 and 71.5%, respectively, suggesting that faecal occult blood testing screening sensitivity may be suboptimal due to testing or programme quality problems. Increasing screening sensitivity might be achieved if the detection rate of advanced adenomas could be increased without unacceptable loss in specificity.
Similar articles
-
Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district.Gut. 2010 Nov;59(11):1511-5. doi: 10.1136/gut.2009.200873. Epub 2010 Jul 5. Gut. 2010. PMID: 20603498
-
Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood.J Med Screen. 2002;9(3):99-103. doi: 10.1136/jms.9.3.99. J Med Screen. 2002. PMID: 12370319
-
Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.Cancer Epidemiol. 2013 Aug;37(4):469-73. doi: 10.1016/j.canep.2013.04.004. Epub 2013 May 14. Cancer Epidemiol. 2013. PMID: 23683843
-
Colorectal carcinoma: is screening possible?Tech Coloproctol. 2004 Dec;8 Suppl 2:s267-72. doi: 10.1007/s10151-004-0174-1. Tech Coloproctol. 2004. PMID: 15666104 Review.
-
Faecal occult blood test as a screening test for colorectal cancer.Acta Gastroenterol Belg. 2005 Apr-Jun;68(2):244-6. Acta Gastroenterol Belg. 2005. PMID: 16013643 Review.
Cited by
-
Validity of fecal occult blood test in the national cancer screening program, Korea.PLoS One. 2013 Nov 8;8(11):e79292. doi: 10.1371/journal.pone.0079292. eCollection 2013. PLoS One. 2013. PMID: 24260189 Free PMC article. Clinical Trial.
-
Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.Gastroenterology. 2019 Dec;157(6):1494-1505. doi: 10.1053/j.gastro.2019.08.023. Epub 2019 Aug 22. Gastroenterology. 2019. PMID: 31472152 Free PMC article.
-
Comparison of a guaiac and an immunochemical faecal occult blood test for the detection of colonic lesions according to lesion type and location.Br J Cancer. 2009 Apr 21;100(8):1230-5. doi: 10.1038/sj.bjc.6604996. Epub 2009 Mar 31. Br J Cancer. 2009. PMID: 19337253 Free PMC article.
-
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD009276. doi: 10.1002/14651858.CD009276.pub2. Cochrane Database Syst Rev. 2022. PMID: 35665911 Free PMC article.
-
Developments in Screening Tests and Strategies for Colorectal Cancer.Biomed Res Int. 2015;2015:326728. doi: 10.1155/2015/326728. Epub 2015 Oct 4. Biomed Res Int. 2015. PMID: 26504799 Free PMC article. Review.
References
-
- Allison JE, Tekama IS, Ransom LJ, Adrian AL (1996) A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334: 155–159 - PubMed
-
- Castiglione G, Zappa M, Grazzini G, Sani C, Mazzotta A, Mantellini P, Ciatto S (1997) Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J Med Screen 4: 142–146 - PubMed
-
- Castiglione G, Zappa M., Grazzini G, Rubeca T, Turco P, Sani C, Ciatto S (2000) Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. J Med Screen 7: 35–37 - PubMed
-
- Church TR, Ederer F, Mandel JS (1997) Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 89: 1440–1448 - PubMed
-
- Clayton D, Hills M (1993) Statistical models in epidemiology. Oxford University Press: Oxford
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials